1,5-benzodiazepine NS5B polymerase inhibitors (Tibotec)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name1,5-benzodiazepine NS5B polymerase inhibitors (Tibotec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Diagnostics BVBA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Diagnostics BVBA
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A